U
Medite Cancer Diagnostics, Inc. MDIT
$0.00 $0.000.00%
Recommendation
--
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)
--

09/30/2018 06/30/2018 03/31/2018 12/31/2017 09/30/2017
Net Income 54.21% 65.35% -46.81% -154.21% -424.51%
Total Depreciation and Amortization -43.64% 25.93% 44.90% 33.33% 107.55%
Total Amortization of Deferred Charges 4,314.29% -- -- 222.12% -94.96%
Total Other Non-Cash Items -87.90% -74.07% -85.12% -72.84% 780.39%
Change in Net Operating Assets -173.60% -220.54% -1,792.86% -11.52% 390.99%
Cash from Operations -77.32% -35.88% -154.42% -3,597.96% -16.33%
Capital Expenditure 31.25% 81.82% 87.50% -1.11% 27.27%
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -- -- -- -- --
Cash from Investing 31.25% 81.82% 87.50% 22.88% -114.55%
Total Debt Issued -80.08% 11,725.00% 18,200.00% 1,189.66% 19,554.17%
Total Debt Repaid 98.81% 72.26% 81.15% -4,800.00% -21,658.33%
Issuance of Common Stock -- -- -- -57.20% --
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- -582.85% --
Cash from Financing -62.18% 15.95% 56.24% -153.95% 6,702.78%
Foreign Exchange rate Adjustments 99.23% -126.12% 69.57% 290.09% -223.70%
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash -96.03% -217.02% -250.93% -2,180.26% 1,548.67%
Weiss Ratings